Patents by Inventor Guang Liang

Guang Liang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12002684
    Abstract: A method for CMP includes following operations. A metal stack is received. The metal layer stack includes at least a first metal layer and a second metal layer, and a top surface of the first metal layer and a top surface of the second metal layer are exposed. A protecting layer is formed over the second metal layer. A portion of the first metal layer is etched. The protecting layer protects the second metal layer during the etching of the portion of the first metal layer. A top surface of the etched first metal layer is lower than a top surface of the protecting layer. The protecting layer is removed from the second metal layer.
    Type: Grant
    Filed: November 21, 2022
    Date of Patent: June 4, 2024
    Assignee: TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LTD.
    Inventors: Ji Cui, Fu-Ming Huang, Ting-Kui Chang, Tang-Kuei Chang, Chun-Chieh Lin, Wei-Wei Liang, Liang-Guang Chen, Kei-Wei Chen, Hung Yen, Ting-Hsun Chang, Chi-Hsiang Shen, Li-Chieh Wu, Chi-Jen Liu
  • Publication number: 20240111597
    Abstract: A present invention embodiment requests resources for a set of tasks from different resource providers. The set of tasks includes first tasks and second tasks of longer duration than the first tasks. The resources are revocable by the different resource providers based on processing demand. Performance of the first tasks is initiated on the resources, and stable resources are identified based on revocation of the resources during performance of the first tasks. Performance of the second tasks are initiated on the identified stable resources. Requests for the resources to the different resource providers are adjusted based on resource provider information collected in response to completion of the set of tasks.
    Type: Application
    Filed: September 30, 2022
    Publication date: April 4, 2024
    Inventors: Guang Han Sui, Wei Ge, Lan Zhe Liu, Guo Liang Wang
  • Patent number: 11913312
    Abstract: An intelligent oil extraction system using an all-metal screw pump includes: the all-metal screw pump, an oil collecting unit (43), and a steam generating unit (45); wherein an internal threaded curve surface and an external threaded curve surface of the all-metal screw pump are both tapered spiral structures with equal tapers; the oil extraction system comprises a lifting mechanism and monitoring and control mechanism; the monitoring and control mechanism comprises: a controller (34), a torque sensor (35), a flow sensor (36), a pressure sensor (39), a liquid level detector (38), and a backup power source (37); the controller (34) is electrically connected to the torque sensor (35), the flow sensor (36), the pressure sensor (39), the liquid level detector (38), the backup power source (37), a drive motor (48), a servo motor (33), a first valve and a second valve.
    Type: Grant
    Filed: October 29, 2019
    Date of Patent: February 27, 2024
    Assignee: WUXI HENGXIN BEISHI TECHNOLOGY CO., LTD
    Inventors: Haiyang Liang, Guang Zhou, Xuelei Sun, Xueling Sun, Zhihai Zhang
  • Patent number: 11555798
    Abstract: Methods and apparatuses for selective monitoring of multiple silicon compounds in etchant solutions are provided. Methods can include reacting a test solution comprising a plurality of different silicon compounds with a fluoride-based compound in several conditions to provide different silicon:reagent binding ratios. One of the conditions can include the addition of a co-solvent to the test solution. Concentrations of the multiple silicon compounds can be determined based on the different binding ratios of silicon:reagent. Methods can further include a measuring method such as silicon elemental analysis or measuring of functional groups of a certain silicon form of a first portion of a test solution comprising a plurality of different silicon compounds and reacting a second portion of the solution with a fluoride-based compound to provide a silicon:reagent binding ratio. Concentrations of the multiple silicon compounds can be determined based on the measuring method and binding ratio measurements.
    Type: Grant
    Filed: September 27, 2019
    Date of Patent: January 17, 2023
    Assignee: ECI TECHNOLOGY, INC.
    Inventors: Eugene Shalyt, Guang Liang
  • Publication number: 20220251017
    Abstract: Provided are a crystal form I of a curcumin derivative (C66), a preparation method therefor and an application thereof. An X-ray powder diffraction pattern of the crystal form I contains following characteristic peaks for 2? reflection angle determination: 8.4±0.2°, 11.5±0.2°, 13.1±0.1°, 16.6±0.2°, 18.8±0.1°, and 21.2±0.1°. No sharp diffraction peak exists at 33.5±0.2° and 38.1±0.2°.
    Type: Application
    Filed: April 26, 2022
    Publication date: August 11, 2022
    Inventors: Guang LIANG, Wenqi WU, Jianchang QIAN, Di WU, Yi WANG
  • Patent number: 10869955
    Abstract: The present invention relates to formulations for administration to a joint fat pad of a subject, and to methods of treating joint pain, inflammation or disease. The disclosed formulations are intended for local administration to the joint fat pad to provide sustained release of a therapeutic agent to the joint cavity and surrounding tissues. The joint may be an arthritic joint, an injured joint or a surgically replaced joint. The therapeutic agent may be an analgesic agent, an anti-inflammatory agent or an immunosuppressive agent. A single administration of the formulation to the joint fat pad delivers a therapeutically effective amount of the therapeutic agent with reduced systemic exposure relative to a single systemic or a single intra-articular administration of a therapeutic dose of an identical therapeutic agent.
    Type: Grant
    Filed: January 28, 2016
    Date of Patent: December 22, 2020
    Assignee: ALLERGAN, INC.
    Inventors: Guang-Liang Jiang, Catherine C. Turkel, Michael E. Stern, Christopher S. Schaumberg, Wendy M. Blanda
  • Publication number: 20200282029
    Abstract: Methods for alleviating osteoarthritis-associated symptoms by selecting a treatment-eligible patient and local administration of a clostridial derivative, such as a botulinum toxin, to an osteoarthritis-affected site are disclosed herein.
    Type: Application
    Filed: January 17, 2020
    Publication date: September 10, 2020
    Inventors: Catherine C. Turkel, Guang-Liang Jiang, Ronald E. DeGryse
  • Publication number: 20200110053
    Abstract: Methods and apparatuses for selective monitoring of multiple silicon compounds in etchant solutions are provided. Methods can include reacting a test solution comprising a plurality of different silicon compounds with a fluoride-based compound in several conditions to provide different silicon:reagent binding ratios. One of the conditions can include the addition of a co-solvent to the test solution. Concentrations of the multiple silicon compounds can be determined based on the different binding ratios of silicon:reagent. Methods can further include a measuring method such as silicon elemental analysis or measuring of functional groups of a certain silicon form of a first portion of a test solution comprising a plurality of different silicon compounds and reacting a second portion of the solution with a fluoride-based compound to provide a silicon:reagent binding ratio. Concentrations of the multiple silicon compounds can be determined based on the measuring method and binding ratio measurements.
    Type: Application
    Filed: September 27, 2019
    Publication date: April 9, 2020
    Applicant: ECI TECHNOLOGY, INC.
    Inventors: Eugene Shalyt, Guang Liang
  • Patent number: 10537619
    Abstract: Methods for alleviating osteoarthritis-associated symptoms by selecting a treatment-eligible patient and local administration of a clostridial derivative, such as a botulinum toxin, to an osteoarthritis-affected site are disclosed herein.
    Type: Grant
    Filed: August 31, 2015
    Date of Patent: January 21, 2020
    Assignee: Allergan, Inc.
    Inventors: Catherine C. Turkel, Guang-Liang Jiang, Ronald E. DeGryse
  • Patent number: 10445998
    Abstract: A motion sensor has an infrared detector with a first set of detector elements coupled to a first channel and a second set of detector elements coupled to a second channel. A first optical subsystem directs infrared radiation from a first number of monitored volumes to the infrared detector and a second optical subsystem directs infrared radiation from a second number of monitored volumes to the infrared detector. Intrusion detection circuitry is coupled to both channels of the infrared detector and selects a set of peaks in the first channel and the second channel. It then calculates an alternation score based on a number of alternating peaks in the set of peaks, and indicates an intrusion detection based, at least in part, on the alternation score. The circuitry also determines a peak-to-peak period for the first channel and calculates a slope-synchrony measurement to modify the alternation score.
    Type: Grant
    Filed: August 14, 2018
    Date of Patent: October 15, 2019
    Inventors: Eric Scott Micko, Guang Liang Zhu
  • Publication number: 20190105380
    Abstract: Methods for modifying progression of osteoarthritis by local administration of a clostridial derivative, such as a botulinum toxin, to an arthritis-affected site are disclosed herein.
    Type: Application
    Filed: December 10, 2018
    Publication date: April 11, 2019
    Inventors: Guang-Liang Jiang, Catherine C. Turkel
  • Publication number: 20190080573
    Abstract: A motion sensor has an infrared detector with a first set of detector elements coupled to a first channel and a second set of detector elements coupled to a second channel. A first optical subsystem directs infrared radiation from a first number of monitored volumes to the infrared detector and a second optical subsystem directs infrared radiation from a second number of monitored volumes to the infrared detector. Intrusion detection circuitry is coupled to both channels of the infrared detector and selects a set of peaks in the first channel and the second channel. It then calculates an alternation score based on a number of alternating peaks in the set of peaks, and indicates an intrusion detection based, at least in part, on the alternation score. The circuitry also determines a peak-to-peak period for the first channel and calculates a slope-synchrony measurement to modify the alternation score.
    Type: Application
    Filed: August 14, 2018
    Publication date: March 14, 2019
    Inventors: Eric Scott Micko, Guang Liang Zhu
  • Publication number: 20170368236
    Abstract: The present invention relates to formulations for administration to a joint fat pad of a subject, and to methods of treating joint pain, inflammation or disease. The disclosed formulations are intended for local administration to the joint fat pad to provide sustained release of a therapeutic agent to the joint cavity and surrounding tissues. The joint may be an arthritic joint, an injured joint or a surgically replaced joint. The therapeutic agent may be an analgesic agent, an anti-inflammatory agent or an immunosuppressive agent. A single administration of the formulation to the joint fat pad delivers a therapeutically effective amount of the therapeutic agent with reduced systemic exposure relative to a single systemic or a single intra-articular administration of a therapeutic dose of an identical therapeutic agent.
    Type: Application
    Filed: January 28, 2016
    Publication date: December 28, 2017
    Inventors: Guang-Liang Jiang, Catherine C. Turkel, Michael E. Stern, Christopher S. Schaumberg, Wendy M. Blanda
  • Publication number: 20170184593
    Abstract: This invention publicizes a chronic renal disease diagnostic kit, comprised of FGF23 monoclonal antibody, biotin labeling reagent Sulfo-NHS-LC-Biotin, PBS buffer solution (pH7.0, 0.1M), casein saline solution, streptomycin avidin and substrate TMB. The labeling condition is the weight ratio of FGF23 antibody and Sulfo-NHS-LC-Biotin, which is 1:5-1:12. The dilution ratio of streptomycin avidin is 1:3000. The lowest testing threshold limit value of FGF23 kit is 10 pg/ml, whose sensitivity is 10 times higher than that of common monoclonal antibody, which is very significant for early diagnose of chronic renal disease.
    Type: Application
    Filed: December 18, 2015
    Publication date: June 29, 2017
    Inventors: Xiaokun Li, Guang Liang, Xiaojie Wang, Shijun Li, Peisheng Hu
  • Publication number: 20170151261
    Abstract: A combination of a prostaglandin EP4 agonist and an effective amount of: a prostaglandin EP2 agonist, a skin growth factor, a small peptide, a small inhibitory RNA targeting excess chronic inflammation or fibrosis, a cytokine with beneficial anti-inflammatory activity, an adenosine A2a receptor agonist, an anti-oxidant, or a combination thereof, may be used to treat skin wounds or scars.
    Type: Application
    Filed: July 1, 2016
    Publication date: June 1, 2017
    Inventors: Guang Liang Jiang, Robert M. Burk, Wha-Bin Im, Larry A. Wheeler
  • Patent number: 9570213
    Abstract: A USB cable (100), comprising: a power wire (1) transferring positive power, a pair of signal wires (2), a metallic braided layer (6) enclosing on the power wire and the signal wires, and an insulative outer jacket (7) surrounding the metallic braided layer. The power wire comprises a metallic inner conductor and an insulative layer surrounding the inner conductor, a mylar film (11) is surrounding on the power wire, and the mylar film is made of Heat Seal PET.
    Type: Grant
    Filed: April 11, 2014
    Date of Patent: February 14, 2017
    Assignee: HON HAI PRECISION INDUSTRY CO., LTD.
    Inventors: Xin-Guang Liang, Shang-Hua Zhao, Lu-Yu Chang
  • Publication number: 20160074485
    Abstract: Methods for alleviating osteoarthritis-associated symptoms by selecting a treatment-eligible patient and local administration of a clostridial derivative, such as a botulinum toxin, to an osteoarthritis-affected site are disclosed herein.
    Type: Application
    Filed: August 31, 2015
    Publication date: March 17, 2016
    Inventors: Catherine C. Turkel, Guang-Liang Jiang, Ronald E. DeGryse
  • Patent number: 9274079
    Abstract: Silicon ions in an alkaline etchant solution are analyzed by acidifying a sample of the etchant solution, adding fluoride ions in excess of the concentration required to react with all of the silicon ions, and using a fluoride ion specific electrode (FISE) to detect free fluoride ions in the resulting test solution. Good sensitivity and precision are provided by using a relatively acidic test solution and only a slight excess of fluoride ions, and limiting the analysis range to the maximum expected silicon concentration in the etchant solution.
    Type: Grant
    Filed: July 15, 2013
    Date of Patent: March 1, 2016
    Assignee: ECI Technology, Inc.
    Inventors: Eugene Shalyt, Guang Liang, Peter Bratin
  • Patent number: 9005605
    Abstract: The specification discloses compositions and methods for treating a soft tissue defect of an individual.
    Type: Grant
    Filed: February 16, 2012
    Date of Patent: April 14, 2015
    Assignee: Allergan, Inc.
    Inventors: Dennis E. Van Epps, Guang-Liang Jiang, Wha Bin Im
  • Publication number: 20150086531
    Abstract: Methods for modifying progression of osteoarthritis by local administration of a clostridial derivative, such as a botulinum toxin, to an arthritis-affected site are disclosed herein.
    Type: Application
    Filed: September 24, 2013
    Publication date: March 26, 2015
    Applicant: Allergan, Inc.
    Inventors: Guang-Liang Jiang, Catherine Turkel